Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
60 /100
HIGH RISK
Score updated Oct 13, 2026

MPLT — MapLight Therapeutics, Inc. Dilution Risk Tracker

Track MPLT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MPLT — Get alerts when the score changes →

As of October 13, 2026, MapLight Therapeutics, Inc. (MPLT) has a DilutionWatch DilutionScore of 60/100, rated HIGH dilution risk. MapLight Therapeutics, Inc. has a market capitalization of $364.95M, 42.44M shares outstanding, 81 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
70
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 12%
📉 Score Deterioration model 25%
• Score climbed 5 points (worsening)
• Score in HIGH risk zone (60/100)
🔔 Track MPLT — Get forecast alerts →

Market Data

Market Cap$364.95M
Shares Outstanding42.44M
Float13.31M
Cash$304.73M
Debt$5.59M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore60/100DilutionWatch score record
Shares Outstanding42.44MVerified float table or market cache
Public Float13.31MVerified float table or market cache
Market Cap$364.95MMarket data cache
Cash Runway19.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 5.2% shares (2026Q1 vs prior)
81 institutional holders · 27.55M shares
#1 GOLDMAN SACHS GROUP INC 3.93M shares
#2 NOVO HOLDINGS A/S 3.69M shares
#3 FCPM III SERVICES B.V. 3.23M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.15M
Days to Cover5.8
% of Float23.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-03-26
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-04-17
4 INSIDER TRANSACTION 2026-04-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual MPLT Dilution Snapshot

MapLight Therapeutics, Inc. (MPLT) has a DilutionScore of 60/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

MPLT's DilutionScore is currently 60/100 (High risk), with 5 score changes tracked over 89 days. The score improved from 55/100 (High risk).

Period Score Risk Level Duration
Oct 13, 202660/100HIGH1 day
Sep 19 – Oct 12, 202655/100HIGH24 days
Sep 16 – Sep 18, 202644/100MEDIUM3 days
Sep 12 – Sep 15, 202655/100HIGH4 days
Aug 14 – Sep 11, 202644/100MEDIUM28 days
Jul 16 – Aug 13, 202643/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

MPLT shares outstanding have increased 0.4% from 42.44M (Mar 2026) to 42.62M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 202642.62M13.31M▼ 3.41%
May 29, 202642.62M13.78M▼ 0.73%
May 28, 202642.62M13.88M▲ 12.88%
May 26, 202642.62M12.30M▼ 0.58%
May 19, 202642.62M12.37M▲ 0.05%
May 17, 202642.62M12.36M▲ 3.00%
May 16, 202642.62M12.00M▼ 11.28%
May 10, 202642.61M13.53M▲ 0.39%
May 04, 202642.61M13.48M▲ 7.25%
Apr 26, 202642.44M12.56M▼ 1.38%
Mar 30, 202642.44M12.74M▲ 2.20%
Mar 28, 202642.44M12.47M▲ 3.74%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track MPLT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment MPLT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking MPLT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MPLT
MPLT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.